HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andreas Lackner Selected Research

N-hydroxy-N'-aminoguanidine

1/2011A novel N-hydroxy-N'-aminoguanidine derivative inhibits ribonucleotide reductase activity: Effects in human HL-60 promyelocytic leukemia cells and synergism with arabinofuranosylcytosine (Ara-C).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andreas Lackner Research Topics

Disease

13Neoplasms (Cancer)
01/2015 - 03/2002
4Leukemia
01/2015 - 06/2007
4Hepatocellular Carcinoma (Hepatoma)
06/2012 - 11/2006
2Pancreatic Neoplasms (Pancreatic Cancer)
10/2013 - 10/2009
2Glioblastoma (Glioblastoma Multiforme)
01/2012 - 09/2008
2Herpes Zoster Oticus (Geniculate Neuralgia)
09/2010 - 09/2008
2Polyps
08/2007 - 11/2006
2Rhinosinusitis
08/2007 - 11/2006
1Nevus (Nevi)
10/2017
1Melanoma (Melanoma, Malignant)
10/2017
1Conductive Hearing Loss
01/2016
1Sensorineural Hearing Loss
06/2013
1Sudden Hearing Loss (Sudden Deafness)
06/2013
1Intracranial Sinus Thrombosis (Sinus Thrombosis)
07/2012
1Carcinoid Tumor (Carcinoid)
01/2012
1Carcinoma (Carcinomatosis)
01/2012
1Vertigo (Positional Vertigo)
12/2011
1Paralysis (Palsy)
09/2010
1Herpes Labialis (Fever Blister)
09/2010
1Hyperthermia
06/2009
1Lymphoma (Lymphomas)
03/2009
1Infections
09/2008
1Nasal Obstruction
08/2007
1Sinusitis
08/2007
1Nasal Polyps (Nasal Polyp)
11/2006
1Inflammation (Inflammations)
11/2006
1Hypersensitivity (Allergy)
07/2003

Drug/Important Bio-Agent (IBA)

7DNA (Deoxyribonucleic Acid)IBA
01/2015 - 11/2006
6Proteins (Proteins, Gene)FDA Link
10/2017 - 08/2007
5Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
10/2013 - 06/2007
4Cytarabine (Cytosar-U)FDA LinkGeneric
01/2015 - 11/2007
3ResveratrolIBA
10/2013 - 11/2007
2Messenger RNA (mRNA)IBA
10/2017 - 08/2007
2PolyphenolsIBA
01/2015 - 10/2009
2EnzymesIBA
10/2013 - 10/2009
2ErbB Receptors (EGF Receptor)IBA
06/2012 - 01/2012
2Green Fluorescent ProteinsIBA
01/2012 - 06/2010
2AvemarIBA
03/2009 - 06/2007
1Biomarkers (Surrogate Marker)IBA
10/2017
1Uric Acid (Urate)IBA
01/2016
1Rosmarinic AcidIBA
01/2015
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
01/2015
1triphosphoric acid (triphosphate)IBA
01/2015
1Ellagic AcidIBA
01/2015
1Free RadicalsIBA
01/2015
1digalloylresveratrolIBA
10/2013
1Indicators and Reagents (Reagents)IBA
06/2013
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
07/2012
1major vault proteinIBA
06/2012
1EverolimusFDA Link
01/2012
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2012
1PuromycinIBA
01/2012
1TOR Serine-Threonine KinasesIBA
01/2012
1N-hydroxy-N'-aminoguanidineIBA
01/2011
1Antiviral Agents (Antivirals)IBA
09/2010
1ProteomeIBA
06/2010
1Cyclin D1IBA
10/2009
1Paclitaxel (Taxol)FDA LinkGeneric
10/2009
1Methylene Chloride (Dichloromethane)IBA
04/2009
1RNA (Ribonucleic Acid)IBA
09/2008
1N- hydroxy- N'- (3,4,5- trimethoxyphenyl)- 3,4,5- trimethoxy- benzamidineIBA
11/2007
1Interleukin-16 (Interleukin 16)IBA
08/2007
1Biological ProductsIBA
11/2006
1Interleukin-5 (Interleukin 5)IBA
11/2006
1activin AIBA
11/2006
1FollistatinIBA
11/2006
1Eosinophil Cationic ProteinIBA
11/2006
1reslizumabIBA
11/2006

Therapy/Procedure

4Therapeutics
10/2017 - 06/2009
3Drug Therapy (Chemotherapy)
01/2011 - 06/2007
1Conservative Treatment
12/2011
1Nasal Surgical Procedures
08/2007
1Intravenous Administration
11/2006
1Intravenous Infusions
11/2006
1Adenoidectomy
07/2003
1Reoperation
03/2002